American Journal of Cardiology
Volume 101, Issue 12 , Pages 1683-1688 , 15 June 2008

Cholesterol Ester Transfer Protein, Interleukin-8, Peroxisome Proliferator Activator Receptor Alpha, and Toll-Like Receptor 4 Genetic Variations and Risk of Incident Nonfatal Myocardial Infarction and Ischemic Stroke

  • Daniel A. Enquobahrie, MD, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
    • Corresponding Author InformationCorresponding author: Tel: 617-432-7153; fax: 617-432-2435.
    • ,
  • Nicholas L. Smith, MPH, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
    • Seattle Epidemiologic Research and Information Center for the Department of Veterans Affairs Office of Research and Development, Seattle, Washington
    • ,
  • Joshua C. Bis, MS, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Medicine, University of Washington, Seattle, Washington
    • ,
  • Cara L. Carty, MS

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
    • ,
  • Kenneth M. Rice, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Biostatistics, University of Washington, Seattle, Washington
    • ,
  • Thomas Lumley, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Biostatistics, University of Washington, Seattle, Washington
    • ,
  • Lucia A. Hindorff, MPH, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
    • ,
  • Rozenn N. Lemaitre, MPH, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Medicine, University of Washington, Seattle, Washington
    • ,
  • Michelle A. Williams, DSc

      Affiliations

    • Department of Epidemiology, University of Washington, Seattle, Washington
    • ,
  • David S. Siscovick, MD, MPH

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
    • Department of Medicine, University of Washington, Seattle, Washington
    • ,
  • Susan R. Heckbert, MD, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
    • Center for Health Studies, Group Health, Seattle, Washington.
    • ,
  • Bruce M. Psaty, MD, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
    • Department of Medicine, University of Washington, Seattle, Washington
    • Department of Health Services, University of Washington, Seattle, Washington
    • Center for Health Studies, Group Health, Seattle, Washington.

Received 6 November 2007 ,Revised 6 February 2008 ,Accepted 6 February 2008.

References 

  1. Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation. 2004;110:1868–1873
  2. Klerkx AH, El Harchaoui K, van der Steeg WA, Boekholdt SM, Stroes ES, Kastelein JJ, et al. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis. Arterioscler Thromb Vasc Biol. 2006;26:706–715
  3. Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond). 2005;108:205–213
  4. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res. 2000;49:497–505
  5. Tai ES, Demissie S, Cupples LA, Corella D, Wilson PW, Schaefer EJ, et al. Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 2002;22:805–810
  6. de Kleijn D, Pasterkamp G. Toll-like receptors in cardiovascular diseases. Cardiovasc Res. 2003;60:58–67
  7. Doney AS, Fischer B, Lee SP, Morris AD, Leese G, Palmer CN. Association of common variation in the PPARA gene with incident myocardial infarction in individuals with type 2 diabetes: A Go-DARTS study. Nucl Recept. 2005;3:4
  8. Yang IA, Holloway JW, Ye S Southampton Atherosclerosis Study (SAS) Group. TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis. Atherosclerosis. 2003;170:187–190
  9. Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol. 2000;20:1323–1329
  10. Thompson JF, Durham LK, Lira ME, Shear C, Milos PM. CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis. 2005;181:45–53
  11. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2004;74:106–120
  12. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978–989
  13. Smith NL, Hindorff LA, Heckbert SR, Lemaitre RN, Marciante KD, Rice K, et al. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA. 2007;297:489–498
  14. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9:811–818
  15. Kooperberg C, Ruczinski I, LeBlanc ML, Hsu L. Sequence analysis using logic regression. Genet Epidemiol. 2001;21(suppl):S626–S631
  16. Ameziane N, Beillat T, Verpillat P, Chollet-Martin S, Aumont MC, Seknadji P, et al. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol. 2003;23(suppl):e61–e64
  17. Holloway JW, Yang IA, Ye S. Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction. Pharmacogenet Genomics. 2005;15:15–21
  18. Kolek MJ, Carlquist JF, Muhlestein JB, Whiting BM, Horne BD, Bair TL, et al. Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes. Am Heart J. 2004;148:1034–1040
  19. Zee RY, Hegener HH, Gould J, Ridker PM. Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis. Stroke. 2005;36:154–157
  20. Norata GD, Garlaschelli K, Ongari M, Raselli S, Grigore L, Benvenuto F, et al. Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J Intern Med. 2005;258:21–27
  21. Lin YC, Chang YM, Yu JM, Yen JH, Chang JG, Hu CJ. Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. Atherosclerosis. 2005;180:305–309
  22. Brousseau ME, O'Connor JJ, Ordovas JM, Collins D, Otvos JD, Massov T, et al. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol. 2002;22:1148–1154
  23. Arca M, Montali A, Ombres D, Battiloro E, Campagna F, Ricci G, et al. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis. Clin Genet. 2001;60:374–380
  24. Blankenberg S, Rupprecht HJ, Bickel C, Jiang XC, Poirier O, Lackner KJ, et al. Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease. J Am Coll Cardiol. 2003;41:1983–1989
  25. Kanda T, Hirao Y, Oshima S, Yuasa K, Taniguchi K, Nagai R, et al. Interleukin-8 as a sensitive marker of unstable coronary artery disease. Am J Cardiol. 1996;77:304–307
  26. Boekholdt SM, Peters RJ, Hack CE, Day NE, Luben R, Bingham SA, et al. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol. 2004;24:1503–1508

 This study was supported by Grants HL73410, HL60739, HL68639, HL43201, HL74745, HL68986, and 1-T32-HL07902 from the National Health Lung and Blood Institute, Bethesda, Maryland.

PII: S0002-9149(08)00349-4

doi: 10.1016/j.amjcard.2008.02.052

American Journal of Cardiology
Volume 101, Issue 12 , Pages 1683-1688 , 15 June 2008

Article Tools